| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0024 | 0.9 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.0028 | 1 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.019 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | sotrastaurin | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |